Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
Recent: |
|
Past: |
|
The U.S. agency that is supposed to safeguard worker health has all but given up on setting limits to protect them from dangerous chemicals. Meanwhile, workers are dying. → Read More
Emails show that NIH officials allowed EcoHealth Alliance to craft oversight language governing its own gain-of-function research. → Read More
The Covid-19 treatment molnupiravir was developed using funding from the National Institutes of Health and the Department of Defense. → Read More
More than 900 pages of materials related to US.-funded coronavirus research in China were released following a FOIA lawsuit by The Intercept. → Read More
When industry wants a chemical safety assessment done yesterday, EPA managers classify it as “hair on fire.” → Read More
EPA managers removed information about the risks posed by dozens of chemicals, according to whistleblowers. → Read More
Pesticide manufacturers that have long dodged regulation by the EPA now face billions in damages for causing cancer, brain damage, and Parkinson’s disease. → Read More
Questions about the origins of Covid-19 raise concerns about the safety of U.S. biolabs. → Read More
Gibson Dunn’s extreme tactics against environmental attorney Steven Donziger spark a backlash. → Read More
Even countries that hosted vaccine trials — like Argentina, South Africa, Brazil, and Turkey — will not receive adequate supplies. → Read More
Facing runoff, Sen. David Perdue says climate change is a hoax, but his beach community is sure worried about rising sea levels. → Read More
Michael McCabe, a former EPA official and aide to Joe Biden, led DuPont’s defense of the toxic PFAS chemical PFOA. → Read More
A new study shows that millions of American have already lost their health care under Trump. → Read More
Amid record unemployment, HHS is doling out more than $1 billion in coronavirus contracts that omit price-gouging safeguards. → Read More
A combination of generic drugs appears to be more effective in fighting the coronavirus than Gilead Sciences’ remdesivir. → Read More
Volunteers in New York City’s “mobile morgues” are handling an onslaught of bodies with scarce supplies. → Read More
Manufacturers can blacklist distributors that charge high prices for N95 masks and other protective gear. → Read More
The EPA has declined to consider the ozone-depleting potential of chemicals released by U.S. companies. → Read More
A strategy report submitted to the European Commission maps out a comprehensive attack on PFAS chemicals, which have contaminated water around the world. → Read More
Pushes to “recycle” plastics are one element of a massive industry-led effort to suppress meaningful efforts to reduce plastic waste. → Read More